Altered antibody profiles after receipt of third dose SARS-CoV-2 mRNA vaccines in solid organ transplant recipients
J. Lee(Johns Hopkins University), Sabra L. Klein(Johns Hopkins University), Maggie Li(Johns Hopkins University), William A. Werbel(Johns Hopkins University), Camille Wouters(Johns Hopkins University), Andrew Pekosz(Johns Hopkins University), Aaron A.R. Tobian(Johns Hopkins University), Andrew H. Karaba(Johns Hopkins University), Janna R. Shapiro(Office of International Affairs), John S. Lee(PhaseBio Pharmaceuticals (United States)), Ioannis Sitaris(Johns Hopkins University), Stephanie R. Peralta(Johns Hopkins University), Joel N. Blankson(Johns Hopkins University)
Cited by 0
Related Papers
Foot strike patterns and collision forces in habitually barefoot versus shod runners
|Nature|2010|1.4k
Impact of sex and gender on COVID-19 outcomes in Europe
|Biology of Sex Differences|2020|1.4k
Clinical Practice Guidelines From the AABB
|JAMA|2016|1.1k
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
|JAMA|2021|1k
Deployment of convalescent plasma for the prevention and treatment of COVID-19
|Journal of Clinical Investigation|2020|863